Healthcare M&A deals worth ₹7,615 crore in FY19 highest in over 5 years: report
5 years, 8 months ago

Healthcare M&A deals worth ₹7,615 crore in FY19 highest in over 5 years: report

Live Mint  

Despite the stress on performance of health sector due to regulatory restrictions, the value of merger and acquisition deals in the sector jumped by a record 155% at ₹7,615 crore in FY19, a report said on Monday. The total value of M&A transactions in the hospital sector in FY19 recorded an increase of 155% amounting to ₹7,615 crore, the highest value in the sector in over five years, as against transactions worth ₹2,991 crore done in FY18, according to rating agency ICRA. The credit goes to the two largest transactions in FY19 which includes acquisition of stakes in Fortis Healthcare for around ₹4,000 crore and Max Healthcare for ₹2,351 crore. "Two largest transactions in FY2019 are the acquisition of stakes in two listed entities -- Fortis Healthcare Limited, ₹4,000 crore, and Max Healthcare Limited, ₹2,351 crore. According to ICRA, the total value of M&A transactions in the hospital sector in FY2019 amounted to ₹7,615 crore, as against transactions worth ₹2,991 crore done in FY2018, recording an increase of 155%.

Healthcare Crore Sector Transactions Icra Fy2019 Fy19 Highest  deals  report  crore  sector  healthcare  7615  worth  regulatory  fy19  highest  transactions  ma  value  acquisition  icra

History of this topic

M&A jumps 60% in Jan-Mar
8 months, 2 weeks ago

M&A jumps 60% in Jan-Mar

New Indian Express  

Merger and acquisition deal value soared by 60% to USD 19.6 billion in January-March 2024, while that of private equity experienced a slight dip, according to a PwC India report. With 455 deals amounting to USD 25.6 billion disclosed value, the first quarter of 2024 showcases a 24% rise in deal volume compared to the fourth quarter of calendar year …

Motilal Oswal reiterates ’buy’ rating for Max Healthcare, expects 15% upside
1 year, 4 months ago

Motilal Oswal reiterates ’buy’ rating for Max Healthcare, expects 15% upside

Live Mint  

Domestic brokerage, Motilal Oswal Financial Services, reiterates 'buy' rating for Max Healthcare with a target price of ₹660, and sees an potential upside of 15% for the stock from Wednesday's close price of ₹575. Max Healthcare's share price is presently trading at 24x FY25E enterprise value /earnings before interest, taxes, depreciation, and amortisation, according to the brokerage, which is higher …

Fortis Healthcare Q4: Net profit up 59% to ₹138.3 cr, dividend declared
1 year, 7 months ago

Fortis Healthcare Q4: Net profit up 59% to ₹138.3 cr, dividend declared

Live Mint  

Fortis Healthcare on Tuesday reported a rise of 58.9 per cent to ₹138.3 crore for the quarter ended March 2023. The revenue from operations was up by 19.2 per cent to ₹1,642.7 crore for the quarter under review as compared to ₹1,378.1 crore in the year ago period. The company board considered and recommended a final dividend of ₹1 per …

M&A deal value in healthcare, pharma hits record high in first half of 2022
2 years, 5 months ago

M&A deal value in healthcare, pharma hits record high in first half of 2022

Live Mint  

India’s healthcare and pharmaceutical sector saw hectic deal activity with the value of merger and acquisitions in the first six months of this calendar year scaling a record high and crossing the total deal value of $3.35 billion in 2021. M&A deal value in the sector touched $4.32 billion during January to June, compared to $2.02 billion in the same …

Discover Related